IBDEI0Q5 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11750,1,4,0)
 ;;=4^N04.5
 ;;^UTILITY(U,$J,358.3,11750,2)
 ;;=^5015536
 ;;^UTILITY(U,$J,358.3,11751,0)
 ;;=N04.6^^46^573^52
 ;;^UTILITY(U,$J,358.3,11751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11751,1,3,0)
 ;;=3^Nephrotic syndrome w/ dense deposit disease
 ;;^UTILITY(U,$J,358.3,11751,1,4,0)
 ;;=4^N04.6
 ;;^UTILITY(U,$J,358.3,11751,2)
 ;;=^5015537
 ;;^UTILITY(U,$J,358.3,11752,0)
 ;;=N04.7^^46^573^53
 ;;^UTILITY(U,$J,358.3,11752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11752,1,3,0)
 ;;=3^Nephrotic syndrome w/ diffuse crescentic glomerulonephritis
 ;;^UTILITY(U,$J,358.3,11752,1,4,0)
 ;;=4^N04.7
 ;;^UTILITY(U,$J,358.3,11752,2)
 ;;=^5015538
 ;;^UTILITY(U,$J,358.3,11753,0)
 ;;=N04.8^^46^573^60
 ;;^UTILITY(U,$J,358.3,11753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11753,1,3,0)
 ;;=3^Nephrotic syndrome w/ other morphologic changes
 ;;^UTILITY(U,$J,358.3,11753,1,4,0)
 ;;=4^N04.8
 ;;^UTILITY(U,$J,358.3,11753,2)
 ;;=^5015539
 ;;^UTILITY(U,$J,358.3,11754,0)
 ;;=N04.9^^46^573^61
 ;;^UTILITY(U,$J,358.3,11754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11754,1,3,0)
 ;;=3^Nephrotic syndrome w/ unspecified morphologic changes
 ;;^UTILITY(U,$J,358.3,11754,1,4,0)
 ;;=4^N04.9
 ;;^UTILITY(U,$J,358.3,11754,2)
 ;;=^5015540
 ;;^UTILITY(U,$J,358.3,11755,0)
 ;;=N05.0^^46^573^49
 ;;^UTILITY(U,$J,358.3,11755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11755,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ minor glomerular abnormality
 ;;^UTILITY(U,$J,358.3,11755,1,4,0)
 ;;=4^N05.0
 ;;^UTILITY(U,$J,358.3,11755,2)
 ;;=^5015541
 ;;^UTILITY(U,$J,358.3,11756,0)
 ;;=N05.1^^46^573^48
 ;;^UTILITY(U,$J,358.3,11756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11756,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ focal & segmental glomerular lesions
 ;;^UTILITY(U,$J,358.3,11756,1,4,0)
 ;;=4^N05.1
 ;;^UTILITY(U,$J,358.3,11756,2)
 ;;=^5015542
 ;;^UTILITY(U,$J,358.3,11757,0)
 ;;=N05.2^^46^573^45
 ;;^UTILITY(U,$J,358.3,11757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11757,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ diffuse membranous glomrlneph
 ;;^UTILITY(U,$J,358.3,11757,1,4,0)
 ;;=4^N05.2
 ;;^UTILITY(U,$J,358.3,11757,2)
 ;;=^5015543
 ;;^UTILITY(U,$J,358.3,11758,0)
 ;;=N05.3^^46^573^46
 ;;^UTILITY(U,$J,358.3,11758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11758,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ diffuse mesangial prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,11758,1,4,0)
 ;;=4^N05.3
 ;;^UTILITY(U,$J,358.3,11758,2)
 ;;=^5015544
 ;;^UTILITY(U,$J,358.3,11759,0)
 ;;=N05.4^^46^573^44
 ;;^UTILITY(U,$J,358.3,11759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11759,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ diffuse endocaplry prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,11759,1,4,0)
 ;;=4^N05.4
 ;;^UTILITY(U,$J,358.3,11759,2)
 ;;=^5015545
 ;;^UTILITY(U,$J,358.3,11760,0)
 ;;=N05.5^^46^573^47
 ;;^UTILITY(U,$J,358.3,11760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11760,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ diffuse mesangiocap glomrlneph
 ;;^UTILITY(U,$J,358.3,11760,1,4,0)
 ;;=4^N05.5
 ;;^UTILITY(U,$J,358.3,11760,2)
 ;;=^5015546
 ;;^UTILITY(U,$J,358.3,11761,0)
 ;;=N05.6^^46^573^42
 ;;^UTILITY(U,$J,358.3,11761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11761,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ dense deposit disease
 ;;^UTILITY(U,$J,358.3,11761,1,4,0)
 ;;=4^N05.6
 ;;^UTILITY(U,$J,358.3,11761,2)
 ;;=^5015547
 ;;^UTILITY(U,$J,358.3,11762,0)
 ;;=N05.7^^46^573^43
